Skip to main content
Veterinary Medicines

Kaltetan, 250 mg/ml + 80 mg/ml + 10 mg/ml solution for infusion for horses, cattle and pigs

Authorised
  • CALCIUM GLUCONATE FOR INJECTION
  • Magnesium chloride hexahydrate
  • Sodium glycerophosphate pentahydrate

Identifikazzjoni tal-prodott

Isem tal-mediċina:
Kaltetan, 250 mg/ml + 80 mg/ml + 10 mg/ml solução para perfusão para equinos, bovinos e suínos
Kaltetan, 250 mg/ml + 80 mg/ml + 10 mg/ml solution for infusion for horses, cattle and pigs
Sustanza attiva:
Metodu ta’ amministrazzjoni:
  • Użu għal ġol-vini

Dettalji tal-prodott

Sustanza attiva / Qawwa:
  • Disponibbli biss fi English
    250.00
    milligram(s)/millilitre
    /
    1.00
    milligram(s)/millilitre
  • Disponibbli biss fi English
    80.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Disponibbli biss fi English
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
Forma farmaċewtika:
  • Soluzzjoni għall-infużjoni
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
      • Milk
        5
        week
    • Pig
      • Meat and offal
        5
        week
    • Cattle
      • Milk
        5
        week
Kodiċi veterinarju anatomiku terapewtiku kimiku (ATCvet):
  • QA12AX
Status tal-awtorizzazzjoni:
  • Valid
Authorised in:
  • Portugal
Available in:
  • Portugal
Deskrizzjoni tal-pakkett:

Tagħrif addizzjonali

Entitlement type:
Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
  • Vet-Agro Multi-Trade Company Sp. z o.o.
Marketing authorisation date:
Siti ta’ manifattura b’rilaxx tal-lott:
  • Multi-Trade Company "Vet-Agro" Sp. z o.o.
Awtorità responsabbli:
  • Directorate General For Food And Veterinary
Numru tal-awtorizzazzjoni:
  • 1495/01/22DFVPT
Data tal-bidla fl-istatus tal-awtorizzazzjoni:
Numru tal-proċedura:
  • PL/V/0110/001
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."